Net secretion of furosemide is subject to indomethacin inhibition, as observed in Caco-2 monolayers and excised rat jejunum.
- 1 January 1999
- journal article
- Published by Springer Nature in Pharmaceutical Research
- Vol. 16 (2) , 221-224
- https://doi.org/10.1023/a:1018868123367
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Drug export activity of the human canalicular multispecific organic anion transporter in polarized kidney MDCK cells expressing cMOAT (MRP2) cDNA.Journal of Clinical Investigation, 1998
- The barrier function of CYP3A4 and P-glycoprotein in the small bowelAdvanced Drug Delivery Reviews, 1997
- Transport properties of the multidrug resistance‐associated protein (MRP) in human tumour cellsFEBS Letters, 1996
- Basolateral localization and export activity of the human multidrug resistance-associated protein in polarized pig kidney cells.Journal of Clinical Investigation, 1996
- Polarized efflux of 2′,7′-bis(2-carboxyethyl)-5(6)-carboxyfluorescein from cultured epithelial cell monolayersBiochemical Pharmacology, 1992
- Furosemide pharmacokinetics and pharmacodynamics in health and disease—An updateJournal of Pharmacokinetics and Biopharmaceutics, 1989
- Evaluation of potential causes for the incomplete bioavailability of furosemide: Gastric first-pass metabolismJournal of Pharmacokinetics and Biopharmaceutics, 1983
- Biotransformation of furosemide in kidney transplant patientsEuropean Journal of Clinical Pharmacology, 1983
- Preliminary evaluation of furosemide–probenecid interaction in humansJournal of Pharmaceutical Sciences, 1980
- Attenuation of furosemide's diuretic effect by indomethacin: Pharmacokinetic evaluationJournal of Pharmacokinetics and Biopharmaceutics, 1979